Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

NCT03283085 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT03283085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03283085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
February 27, 2018
Completion date
December 13, 2023
Enrollment
557 (actual)
Sites
419

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, ulcerative colitis